These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10078718)

  • 21. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxcarbazepine for epilepsy--a useful new choice?
    Drug Ther Bull; 2002 Jun; 40(6):46-8. PubMed ID: 12143266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
    French JA; Krauss GL; Steinhoff BJ; Squillacote D; Yang H; Kumar D; Laurenza A
    Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spotlight on oxcarbazepine in epilepsy.
    Bang LM; Goa KL
    CNS Drugs; 2004; 18(1):57-61. PubMed ID: 14731060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxcarbazepine add-on for drug-resistant partial epilepsy.
    Castillo S; Schmidt DB; White S
    Cochrane Database Syst Rev; 2000; (3):CD002028. PubMed ID: 10908522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxcarbazepine: an update of its efficacy in the management of epilepsy.
    Wellington K; Goa KL
    CNS Drugs; 2001; 15(2):137-63. PubMed ID: 11460891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy.
    Beydoun A; Sachdeo RC; Kutluay E; McCague K; D'Souza J
    Epilepsia; 2003 Sep; 44(9):1160-5. PubMed ID: 12919387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy.
    Sachdeo RC; Gates JR; Bazil CW; Barkley GL; Tatum W; D'Souza J; McCague K
    Epilepsy Behav; 2006 Nov; 9(3):457-63. PubMed ID: 16934534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures.
    Piña-Garza JE; Espinoza R; Nordli D; Bennett DA; Spirito S; Stites TE; Tang D; Sturm Y
    Neurology; 2005 Nov; 65(9):1370-5. PubMed ID: 16275822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial.
    Brodie MJ; Rosenfeld WE; Vazquez B; Sachdeo R; Perdomo C; Mann A; Arroyo S
    Epilepsia; 2009 Aug; 50(8):1899-909. PubMed ID: 19490053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxcarbazepine approved for partial seizures.
    Miller JL
    Am J Health Syst Pharm; 2000 Mar; 57(5):414, 417. PubMed ID: 10711517
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
    Elger C; Halász P; Maia J; Almeida L; Soares-da-Silva P;
    Epilepsia; 2009 Mar; 50(3):454-63. PubMed ID: 19243424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical feasibility of immediate overnight switching from slow-release carbamazepine to oxcarbazepine in Korean patients with refractory partial epilepsy.
    Lee SA; Heo K; Kim WJ; Song HK; Kim SE; Kim SH; No SK; Lee BI
    Seizure; 2010 Jul; 19(6):356-8. PubMed ID: 20538492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch.
    Albani F; Grassi B; Ferrara R; Turrini R; Baruzzi A;
    Seizure; 2004 Jun; 13(4):254-63. PubMed ID: 15121136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel.
    Montouris G; Yang H; Williams B; Zhou S; Laurenza A; Fain R
    Epilepsy Res; 2015 Aug; 114():131-40. PubMed ID: 26088896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Felbamate monotherapy for partial-onset seizures: an active-control trial.
    Faught E; Sachdeo RC; Remler MP; Chayasirisobhon S; Iragui-Madoz VJ; Ramsay RE; Sutula TP; Kanner A; Harner RN; Kuzniecky R
    Neurology; 1993 Apr; 43(4):688-92. PubMed ID: 8469323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy and safety of the monotherapy with trileptal (oxcarbazepine) in children and adolescents].
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Suppl 1):45-50. PubMed ID: 20559267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of lamotrigine and oxcarbazepine monotherapy for pediatric focal epilepsy: An observational study.
    Hur YJ
    Seizure; 2018 Aug; 60():123-126. PubMed ID: 29957441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Perampanel in treatment of refractory partial epilepsy in adolescents and adults: results of international multicenter randomized, double-blind, placebo-controlled phase III studies].
    Belousova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(8):32-8. PubMed ID: 25345628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group.
    Beydoun A; Sackellares JC; Shu V
    Neurology; 1997 Jan; 48(1):182-8. PubMed ID: 9008516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.